Here we took advantage of a large database of patient electronic health records (EHRs) to conduct a nationwide multicenter retrospective cohort study to assess the association of semaglutide with both the incidence and recurrence of AUD in individuals with obesity and with and without a prior history of AUD
Semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro, licensed for type 2 diabetes in the UK)a dual GLP-1/GIP receptor agonistare highly effective but are associated with gastrointestinal side effects that are dose-dependent
For behavioral studies, data were analyzed by ANCOVA, or repeated-measures one-way or two-way ANOVA followed by Tukeys or Bonferronis post hoc test as appropriate
Here are concerns experts say you should weigh: GLP-1s Could Change How Well Your Bipolar Medications Work When your gut slows down, its not just food that sits around
PlexusDx Precision Peptide Genetic Test ($298) identifies variants in GIPR and FTO, and MC4R genes that influence appetite and weight loss response
To help reduce nausea, physicians commonly recommend: Eating smaller, more frequent meals Eating slowly Avoiding large portions Choosing bland foods during symptomatic periods Remaining upright after meals Vomiting Some patients experience vomiting, especially during the early stages of treatment or shortly after dose increases